Daptomycin Versus Other Antimicrobial Agents for the Treatment of Skin and Soft Tissue Infections: A Meta-Analysis

2010 ◽  
Vol 44 (1) ◽  
pp. 97-106 ◽  
Author(s):  
loannis A Bliziotis ◽  
Eleni Plessa ◽  
George Peppas ◽  
Matthew E Falagas





Pharmaceutics ◽  
2021 ◽  
Vol 13 (12) ◽  
pp. 2151
Author(s):  
Ashwini Rahul Akkineni ◽  
Janina Spangenberg ◽  
Michael Geissler ◽  
Saskia Reichelt ◽  
Hubert Buechner ◽  
...  

Soft tissue infections in open fractures or burns are major cause for high morbidity in trauma patients. Sustained, long-term and localized delivery of antimicrobial agents is needed for early eradication of these infections. Traditional (topical or systemic) antibiotic delivery methods are associated with a variety of problems, including their long-term unavailability and possible low local concentration. Novel approaches for antibiotic delivery via wound coverage/healing scaffolds are constantly being developed. Many of these approaches are associated with burst release and thus seldom maintain long-term inhibitory concentrations. Using 3D core/shell extrusion printing, scaffolds consisting of antibiotic depot (in the core composed of low concentrated biomaterial ink 3% alginate) surrounded by a denser biomaterial ink (shell) were fabricated. Denser biomaterial ink (composed of alginate and methylcellulose or alginate, methylcellulose and Laponite) retained scaffold shape and modulated antibiotic release kinetics. Release of antibiotics was observed over seven days, indicating sustained release characteristics and maintenance of potency. Inclusion of Laponite in shell, significantly reduced burst release of antibiotics. Additionally, the effect of shell thickness on release kinetics was demonstrated. Amalgamation of such a modular delivery system with other biofabrication methods could potentially open new strategies to simultaneously treat soft tissue infections and aid wound regeneration.



2021 ◽  
Vol 1 ◽  
pp. 61
Author(s):  
Rashmi Sarkar ◽  
Sushil Tahiliani ◽  
Amit Madan ◽  
Anil Abraham ◽  
Anil Ganjoo ◽  
...  

Dermatologists often come across cases of skin and soft-tissue infections (SSTIs) which have diverse clinical presentations. Various local, systemic, and environmental risk factors predispose an individual to develop SSTIs. Topical antimicrobial agents are frequently used in superficial uncomplicated SSTIs, whereas systemic therapy is generally reserved for use in severe cases. However, emergence of resistance to these agents is becoming a common problem in clinical practice. This necessitates the use of other classes of antimicrobials for the effective treatment of SSTIs. Nadifloxacin, a potential drug belonging to the fluoroquinolone group, has various advantages such as binding to bacterial DNA gyrase and topoisomerase IV enzymes, inhibition of nor-A efflux pump, survival in acidic pH, anti-MRSA activity, and biofilms penetration. It has also shown least development of resistance since its introduction. Although its topical formulation has shown superior efficacy as an anti-acne agent, there are no specific guidelines for its appropriate use in SSTIs. Hence, a panel of experts was formed, under whose guidance an extensive literature search was performed in MEDLINE, Cochrane Library, and Science Direct databases. Using the modified Delphi technique, the available evidence was reviewed and corresponding recommendations were given for the use of topical Nadifloxacin as an empirical treatment in SSTIs.



PLoS ONE ◽  
2019 ◽  
Vol 14 (10) ◽  
pp. e0223513
Author(s):  
Po-Yao Chuang ◽  
Tien-Yu Yang ◽  
Tsan-Wen Huang ◽  
Yao-Hung Tsai ◽  
Kuo-Chin Huang ◽  
...  




2018 ◽  
Vol 7 (1) ◽  
Author(s):  
Jessica J. Bartoszko ◽  
Dominik Mertz ◽  
Lehana Thabane ◽  
Mark Loeb


Surgery ◽  
2021 ◽  
Author(s):  
Chathurika S. Dhanasekara ◽  
Brianna Marschke ◽  
Erin Morris ◽  
Chanaka N. Kahathuduwa ◽  
Sharmila Dissanaike


Sign in / Sign up

Export Citation Format

Share Document